Staging of hepatocellular carcinoma
Staging of hepatocellular carcinoma作者机构：Department of General SurgerySection of HPB Surgery and Organ TransplantationAnkara Guven HospitalAnkara 06540Turkey
出 版 物：《Hepatoma Research》 (肝癌研究（英文版）)
年 卷 期：2018年第4卷第9期
页 面：93-110页
学科分类：1002[医学-临床医学] 100214[医学-肿瘤学] 10[医学]
主 题：Hepatocellular cancer staging and scoring systems risk factors survival
摘 要：Hepatocellular carcinoma (HCC) is the third leading cause of cancer deaths in the world. In contrast to other cancers, survival of patients with HCC is determined by the extent of the tumor in addition to underlying liver disease and its functional reserve. From risk factors to management, HCC reveals a considerable geographic and institutional variation throughout the world. Although many staging and/or scoring systems have been proposed, each prognostic system has several benefits and limitations on its own. Therefore, there is currently no globally accepted system for HCC due to the extreme heterogeneity of the disease. In this review, currently available staging systems for assessing the prognosis of HCC, their uses, limitations, and future prospects are revisited.
维普期刊数据库